EFFICACY OF SIROLIMUS ELUTING STENTS IMPLANTATION IN DIFFUSE (LONG AND EXTREMELY LONG) CORONARY ATHEROSCLEROTIC LESIONS
https://doi.org/10.15829/1560-4071-2017-8-42-50
Abstract
Aim. Comparison of efficacy of stents coated with sirolimus (group I — 116 patients), and bare metallic stents (group II — 117 patients) in treatment of diffuse (long) atherosclerotic lesions in coronary arteries.
Material and methods. The groups were comparable by main parameters. Diabetes was found in 19% and 13,7%, respectively; multivessel lesion in 87,1% and 80,4%; vessel caliber less than 2,75 mm — 46,5% and 23,9%, respectively. Length of the lesion was 25,9±6,6 mm (28-93 mm) in group I and 22,1±7,8 mm (26-102 mm) in group II. Totally, 473 stents implanted into 232 arteries (2,1 per artery): group I — 184 stents in 116 arteries (overlap of 2> stents in 87,9% cases) and 289 in 117 in group II (superposition of stents in 87,1%).
Results. The direct success at short term was noted in 113 patients in group I (97,4%) and in 116 in group II (99,1%) (p=0,74). In both groups there were no cases of acute thrombosis of stents. Subacute thrombosis (in 1-3 weeks) was noted in 2 patients (1,7%) in group I and in 1 (0,85%) in group II (p=0,47). Long term angiographic restenosis was noted in 12 patients from group I (10,6%) and in 66 in group II (56,9%) (p<0,0025). Also, in group II 47 patients from 66 had diffuse restenosis (71,2%), as in group I there was no diffuse restenosis. Survival rate with no MACE or angina in 12 months was 79,8% in group I, and 31% in group II.
About the Authors
A. M. Babunashvili
The Center of Endosurgery and Lithotripsy
Russian Federation
Russian Federation
D. S. Kartashov
The Center of Endosurgery and Lithotripsy
Russian Federation
Russian Federation
V. E. Babokin
Moscow Regional Research and Clinical Institute (MONIKI)
Russian Federation
Russian Federation
I. G. Ozashvili
Moscow Regional Research and Clinical Institute (MONIKI)
I. E. Yudin
I.M. Sechenov First Moscow State Medical University of the Ministry of Health
Russian Federation
Russian Federation
References
1. De Feyter PJ, van den Brand M, Laarman G, et al. Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty. Frequency, prediction, clinical course management and follow-up. Circulation; 1991, 83: 927-36.
2. Lincoff AM, Popma JJ, Eliis SG, Hacker J. Abrupt vessel closure complicating coronary angioplasty: Clinical, angiographic and therapeutic profile. J Am Coll Cardiol.; 1992, 19: 926-35.
3. Kaul U, Upasani PT, Agarwal R, et al. In-hospital outcome of percutaneous transluminal coronary angioplasty for long lesions and diffuse coronary artery disease. Catheter Cardiovasc Diagn, Aug 1995; 35(4): 294-300.
4. Di Sciascio G, Patti G, Nasso G, et al. Early and long-term results of stenting of diffuse coronary artery disease. Am J Cardiol, Dec 2000; 86 (11): 1166-70.
5. Mayoux G, Cantie P, Mourali S, et al. Implantation of long coronary stents. Immediate amd long-term results. Arch Mal Couer Vaiss, Jan 2000; 93 (1): 11-8.
6. Rodionov AL, Rafaeli YR, Babokin VE. Functioning of aortocoronary bypass grafts depending on the lesion and on the anatomical characteristics of coronary arteries. Almanac of Clinical Medicine. 2017; 45 (3): 181-5. Russian (Родионов А. Л., Рафаели И. Р., Бабокин В. Е. Функционирование аортокоронарных трансплантатов в зависимости от поражения и анатомических особенностей коронарных артерий. Альманах клинической медицины. 2017; 45 (3): 181-5). doi:10.18786/2072-0505-2017-45-3-181-185
7. Sheiban I, Carrieri L, Catuzzo B, et al. Drug-eluting stent: the emerging technigue for the prevention of restenosis. Minerva Cardioangiol, Oct 2002; 50 (5): 443-53.
8. Bigi R, Cortigiani L, Colombo P, et al. Prognostic and clinical correlates of angiographically diffuse coronary lesions. Heart, Sep 2003; 89 (9): 1009-13.
9. Belov UV, Sanay EV. Endocardectomy from coronary arteries for disuse lesion of coronary vascular bed. Khirurgiya 2003; 10: 81-3. Russian (Белов Ю. В., Санай Е. В. Эндартерэктомия из коронарных артерии при диффузном поражений коронарного русла. Хирургия, 2003; 10: 81-3).
10. Baev B, Iliev R, Lakimov T, et al. Multiple cononary endarterectomy in patients with diffusial coronary disease. Khirurgiia (Sofiia) 2004; 60 (3): 9-11.
11. Cherian KM, Ajit M, Sankar NM. The role of endarterectomy and TMR in diffuse coronary artery disease. Ann Thorac Surg, Sep 2001; 72 (3): 976-7.
12. Stamou SC, Boyce SW, Cooke RH, et al. One-year outcome after combined coronary artery bypass grafting and transmyocardial laser revascularization for refractory angina pectoris. Am J Cardiol, Jun 2002; 89 (12): 1365-8.
13. Horvath KA. Results of clinical trials of transmyocardial laser revascularization versus medical management for end-stage coronary disease. J Clin laser Med Surg, Oct 2000; 18 (5): 247-52.
14. Shipulin VM, Andreev SL, Sukhodolo IV, et al. Development of transmyocardial laser revascularization in patients with ischemic heart disease. Almanac of Clinical Medicine. 2015; 38: 81-9. Russian (Шипулин В. М., Андреев С. Л., Суходоло И. В., и др.
15. Разработка трансмиокардиальной лазерной реваскуляризации миокарда у пациентов с ишемической болезнью сердца. Альманах клинической медицины. 2015; 38: 81-9). DOI:10.18786/2072-0505-2015-38-81-89
16. Bernheim MW. Transmyocardial laser revascularization. AANA J, Jun 2001; 69 (3): 195-7.
17. Hayat N, Shafie M, Gummaa MK, Khan N. T ransmyocardial laser revascularization: is the entisiasm justified? Clin Cardiol, Apr 2001; 24 (4): 321-4.
18. Oesterle SN, Reifart N, Hauptmann E, et al. Percutaneous in situ coronary venous arterialization: report of the first human catheter-based coronary artery bypass. Circulation, May 2001; 103 (21): 2539-43.
19. Huwer H, Welter C, Ozbek C, et al. Simultaneous surgical revascularization and angiogenic gene therapy in diffuse coronary artery disease. Eur J Cardiothorac Surg, Dec 2001; 20 (6): 1128-34.
20. Cowley MG, Dorros G, Kelsey SF, et al. Acute coronary events associated with percutaneous transluminal coronary angioplasty. Am J Cardiol.; 1984, 53: 12C.
21. Sinclair IN, McCabe CH, Sipperly ME, Baim DS. Predictors, therapeutic options, and longterm outcome of abrupt reclosure. Am J Cardiol.; 1988, 61 (Suppl. G); 61G.
22. Detre KM, Holmes DR, Holubrov R, et al. Incidences and consequences of periprocedural occlusion. The 1985-1986 National Heart, Lung and Blood Institute PTCA-registry. Circulation; 1990, 82: 739-48.
23. Ellis SG, Roubin GS, King SB III, et al. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation; 1988, 77: 372-6.
24. Simpfendorfer C, Belardi J, Ballamy G, et al. Frequency management, and follow-up of patients with acute coronary occlusions after percutaneous transluminal coronary angioplasty. Am J Cardiol.; 1987, 59: 267-77.
25. Cavallina C. Clinical, angiographic and procedural factors predicting coronary restenosis after stent implantation: synthesis of the evidence. Ital Heart J Suppl, Jul 2001; 2 (7): 719-32.
26. Wong P, Lau KW, Lim YL, Oesterle SN. Stent placement for non-STRESS/BENESTENT lesions: a critical review. Catheter Cardiovasc Interv, Oct 2000; 51 (2): т223-33.
27. Goldberg SL, Loussararian A, De Gregorio G, et al. Predictors of diffuse and aggressive intra-stent restenosis. J Am Coll Cardiol, Mar 2001; 37 (4): pp. 1019-25.
28. Degertekin M, Serruys P, Foley DP, et al. Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic and intravascular ultrasound follow-up. Circulation, Sep 2002; 106 (13): 1610-3.
29. Muller R, Bullesfeld L, Gerckens U, Grube E. S tate of treatment of coronary artery disease by drug releasing stents. Herz, Sep 2002; 27 (6): 508-13.
30. Serruys PW, Di Mario C. Who was thrombogenic: the stent or the doctor? Circulation, Mar 1995; 91(6): 1891-3.
31. Tardif JC. The future of intravascular ultrasound in the detection and management of coronary artery disease. Clin J Cardiol, Jul 2000; 16 Suppl D: 12D-5D.
32. Tanigawa T, Ishiwata S, Yamamoto T, et al. Influence of diabetic mellitus on the initial and long-term outcome of patients treated with coronary stenting. J Cardiol, Mar 2002; 39 (3): 133-40.
Review
For citations:
Babunashvili A.M., Kartashov D.S., Babokin V.E., Ozashvili I.G., Yudin I.E. EFFICACY OF SIROLIMUS ELUTING STENTS IMPLANTATION IN DIFFUSE (LONG AND EXTREMELY LONG) CORONARY ATHEROSCLEROTIC LESIONS. Russian Journal of Cardiology. 2017;(8):42-50. (In Russ.) https://doi.org/10.15829/1560-4071-2017-8-42-50
Views:
923
Email this article 